Shingles Vaccine Shortages Result From High Demand

Shingrix, the vaccine approved last year to prevent shingles, has proved so popular that its maker, GlaxoSmithKline, has not been able to produce it quickly enough.

Source: NYT Health - September 25, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Shingles (Disease) Shortages Vaccination and Immunization Drugs (Pharmaceuticals) Drugstores Source Type: news